Vivi M. Srivastava

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity

Vikram Mathews, Biju George, Kavitha M. Lakshmi et al. · Blood · 2005 · 342 citations · Full text

Medicine, Hematology, Oncology +12

Acute myeloid leukaemia: challenges and real world data from India

Chepsy C Philip, Biju George, Abhijeet Ganapule et al. · British Journal of Haematology · 2015 · 126 citations · Full text

Medicine, Hematology, Oncology +13

Long-Term Cultured Human Term Placenta-Derived Mesenchymal Stem Cells of Maternal Origin Displays Plasticity

Vikram Sabapathy, Saranya Ravi, Vivi M. Srivastava et al. · Stem Cells International · 2012 · 59 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +15

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy

Ezhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George et al. · Blood · 2012 · 57 citations · Full text

Medicine, Hematology, Oncology +15

Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance

Ezhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex et al. · PLoS ONE · 2015 · 52 citations · Full text

Medicine, Hematology, Oncology +14